In vitro evaluation of marketed antimalarial chloroquine phosphate tablets

Journal of Vector Borne Diseases

Volumn 42, Issue 4, 2005, Pages 147-150

  Patel, Amit Kantilal ^a   Prajapati, Bhupendra G ^a   Moria, Rubina S ^a   Patel, Chhaganbhai N ^a  

^a Shri Sarvajanik Pharmacy College   (India)

Author keywords

Chemical equivalence; Chloroquine phosphate tablets; Friability

Indexed keywords

CHLOROQUINE;

ARTICLE; BIOEQUIVALENCE; CRUSHING STRENGTH; DRUG MARKETING; DRUG QUALITY; DRUG SOLUBILITY; EVALUATION RESEARCH; HUMAN; IN VITRO STUDY; MALARIA; PHYSICAL CHEMISTRY; STATISTICAL SIGNIFICANCE; TABLET DISINTEGRATION; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET WEIGHT;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; HUMANS; QUALITY CONTROL; TABLETS;

EID: 30844438515     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Covington TR. Generic drug utilization: overview and guidelines for prudent use. Clin Res Reg Affairs 1992; 9: 103-26.
2. Shah HK. Generics capture new prescription markets. Perspect Pharma Econ 1992; 4: 3.
3. Expert committee on specifications for pharmaceutical preparations. 34 Report. WHO Tech Rep Ser No. 863. Geneva: WHO 1996:114-54
4. Itiola OA, Pilpel N. Effects of interacting variables on the disintegration and dissolution of metronidazole tablets. Pharmazie 1996; 51: 987-9.
5. British Pharmacopoeia. London: The Pharmaceutical Press, Her Majesty's Stationery Office 1998; 1: 379, 969 & 1242.
6. United State Pharmacopoeia National Formulary 25, Asian edn. Rockville: United State Pharmacopoeial Convention Inc, 2002: p. 394-5.
7. Modern pharmaceutics. In: Banker G, Rhodes CT editors. New York: Dekker 1979: 273-5.